Stock NDAT NDATALYZE CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News nDatalyze Corp.

Equities

NDAT

CA63948H1055

Market Closed - Canadian Securities Exchange
Other stock markets
 09:30:00 2024-04-18 am EDT 		5-day change 1st Jan Change
0.15 CAD 0.00% Intraday chart for nDatalyze Corp. -3.23% +11.11%
Apr. 18 NDatalyze Corp. announced that it expects to receive CAD 0.20625 million in funding CI
Apr. 16 Ndatalyze Corp. Announces Executive Changes CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) Announces a Private Placement and Provides an Update by its New President, Joshua Hill
AQ
NDatalyze Corp. announced that it expects to receive CAD 0.20625 million in funding
CI
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) announces the closing of the Mindbalanced Inc. acquisition and the appointment of Joshua Hill as President.
AQ
Ndatalyze Corp. Announces Executive Changes
CI
NDatalyze Corp. completed the acquisition of Mindbalanced Inc.
CI
NDatalyze Corp. Announces a Formal Agreement with the Canadian Mental Health Association, Dr. Andrew Greenshaw, and Dr. Bo Cao.
AQ
Canadian Investment Regulatory Organization Trade Resumption - NDAT
AQ
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) announces an agreement to acquire Mindbalanced Inc.
AQ
Canadian Investment Regulatory Organization Trading Halt - NDAT
AQ
NDatalyze Corp. entered into an agreement to acquire Mindbalanced Inc. for CAD 2.2 million.
CI
NDatalyze Corp. is Pleased to Review its Advanced Mental Condition Diagnostic System that Promises to Fundamentally Change Mental Health Diagnosis, Management and Treatment
AQ
NDatalyze Corp. Completes its DNA-Enhanced Records Gathering
AQ
NDatalyze Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023
CI
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) Operational Update and Business Model Explanation
AQ
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) signs a formal Clinical Study agreement with Dr. Dale Stevens, Ph.D., Department of Psychology, Faculty of Health, York University.
AQ
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) announces a Letter of Intent with the Canadian Mental Health Association, Dr. Andrew Greenshaw, and Dr. Bo Cao.
AQ
Ndatalyze Corp. Extends the Letter of Intent to January 15, 2024
CI
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) Extends the Letter of Intent with Dr. Dale Stevens, Ph.D., Department of Psychology, Faculty of Health, York University
AQ
Ndatalyze Corp. Announces a Binding Clinical Study Agreement with Personalized Prescribing Inc
CI
NDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) announces a binding Clinical Study Agreement.
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NDAT Stock
  4. News nDatalyze Corp.